Jun 18, 2026 08:00AM
Jun 18, 2026 08:00AM
May 21, 2026 06:00PM
May 21, 2026 06:00PM
May 7, 2026 05:57PM
May 7, 2026 04:01PM
Apr 20, 2026 08:30AM When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech
Apr 6, 2026 05:55AM
Apr 3, 2026 01:30PM
Mar 25, 2026 11:50AM
Mar 25, 2026 11:50AM
Feb 26, 2026 05:21PM
Feb 26, 2026 04:01PM
Dec 30, 2025 08:00AM Denali's Hunter syndrome drug shows promise in published study
Dec 30, 2025 08:00AM
Dec 4, 2025 07:10AM
Dec 4, 2025 07:02AM
Dec 4, 2025 07:00AM
Nov 6, 2025 06:48PM
Nov 6, 2025 04:01PM
Nov 6, 2025 04:00PM Denali Therapeutics names new board member, chief medical officer
Nov 6, 2025 04:00PM
Oct 13, 2025 04:01PM
Oct 13, 2025 04:01PM
Aug 11, 2025 04:03PM
Aug 11, 2025 04:01PM
Jul 7, 2025 08:03AM
Jul 7, 2025 08:00AM Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
May 6, 2025 05:38PM
May 6, 2025 04:01PM
Apr 2, 2025 08:04AM
Apr 2, 2025 08:00AM
Feb 27, 2025 05:02PM
Feb 27, 2025 04:01PM
Nov 6, 2024 04:01PM Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
Aug 1, 2024 08:51AM
Aug 1, 2024 06:45AM
May 7, 2024 06:35PM
May 7, 2024 04:01PM
Feb 27, 2024 09:30AM
Feb 27, 2024 08:05AM
Jan 8, 2024 08:00AM Denali Therapeutics Announces Key Anticipated 2024 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases
Nov 7, 2023 05:23PM
Nov 7, 2023 04:01PM
Aug 8, 2023 05:18PM
Aug 8, 2023 04:01PM
May 8, 2023 04:49PM
May 8, 2023 04:01PM
Feb 27, 2023 04:39PM Denali Therapeutics Inc. (DNLI) Tops Q4 EPS by 4c
Feb 27, 2023 04:01PM

1,199,626 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All